La Merie

La Merie is a provider of information about biopharmaceutical R&D and competitive intelligence by Publishing, Consultancy and its Biotech Portal PipelineReview.com. La Merie produces, edits and publishes La Merie Daily, R&D Pipeline News, Competitor Analysis reports and full reports.

Results 1 - 20 of 78

previous 1 2 3 4 next

last

Title	Date	Price
Competitor Analysis: EGF-R Agonists and Antagonists	Oct 2009	£270
Competitor Analysis: Coagulation Factors	Oct 2009	£450
Competitor Analysis: Her2 Receptor Antagonists	Sep 2009	£225
Competitor Analysis VEGF and VEGF-R Agonists and Antagonists	Sep 2009	£540
CHK and KSP/Eg5 Inhibitors Competitor Analysis	Aug 2009	£160
Competitor Analysis: Targeted Therapy of Hepatitis C	Aug 2009	£450
Coagulation Factors 2009 Target Pipeline and Corporate Benchmark Analysis	Aug 2009	£2,215
PI3K-Akt-mTOR Pathway Inhibitors Competitor Analysis	Jul 2009	£450
Immunotoxins Competitor Analysis	Jul 2009	£135
Bcr-Abl Kinase Inhibitors Competitor Analysis	Jul 2009	£180
IGF-1R Antagonists Competitor Analysis	Jul 2009	£225
HDAC Inhibitors Competitor Analysis	Jul 2009	£360
Antibody-Drug Conjugates (ADC) Competitor Analysis	Jun 2009	£225
MEK Inhibitors Competitor Analysis	Jun 2009	£135
Aurora Kinase Inhibitors Competitor Analysis	Jun 2009	£160
Immunocytokines Competitor Analysis	Jun 2009	£135
Novel Mitotic Kinase Inhibitors Competitor Analysis	May 2009	£315
Raf Inhibitors Competitor Analysis	May 2009	£180
Elastase Inhibitors Competitor Analysis	May 2009	£180
Ras-Raf-MEK-ERK Inhibitors Competitor Analysis	May 2009	£315